Evaluation of the effect of high protein supply on diaphragm atrophy in critically ill patients receiving prolonged mechanical ventilation

Nutr Clin Pract. 2022 Apr;37(2):402-412. doi: 10.1002/ncp.10672. Epub 2021 Jun 8.

Abstract

Background: Our aim was to evaluate the effect of high protein to the target of 2.0 g/kg/d on diaphragm atrophy and clinical prognosis of patients receiving prolonged mechanical ventilation (MV).

Methods: This prospective, randomized, controlled, single-center study included 41 patients who were treated with ≥7 days' MV. The patients were randomly divided into a standard nutrition treatment (SNT) group and intensive nutrition treatment (INT) group, followed by evaluation of computer tomography-analyzed diaphragm volume, the level of butyrylcholinesterase (BChE) as a muscle mass indicator, and respiratory mechanics indices weekly to observe and compare the differences between the groups.

Results: In the INT group, the actual protein (1.70 ± 0.21 vs 1.06 ± 0.21 g/kg/d, P < .001) and calorie intake (33.46 ± 2.78 vs 25.75 ± 4.81 kcal/kg/d, P < .001) were significantly different from those of the SNT group. Compared with the SNT group, the INT group's diaphragm atrophy improved in the fourth and fifth weeks (all P < .05). The BChE after the third week was higher (all P < .05). No significant differences in respiratory mechanical indices and clinical outcomes were found in the surviving patients between the groups.

Conclusion: INT improved the diaphragm atrophy and muscle mass of critically ill patients receiving prolonged MV. There was no evidence that increasing protein to the target amount of 2.0 g/kg/d is related to improvement in clinical prognosis for patients receiving prolonged MV.

Keywords: calorie intake; critical illness; enteral nutrition; mechanical ventilation; protein intake.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Atrophy / etiology
  • Atrophy / pathology
  • Butyrylcholinesterase
  • Critical Illness* / therapy
  • Diaphragm / diagnostic imaging
  • Diaphragm / pathology
  • Humans
  • Prospective Studies
  • Respiration, Artificial*

Substances

  • Butyrylcholinesterase